2nd Quarter - Report

KNIGHT CAPITOL CONSULTANTS for GENZYME CORPORATION

Period 2nd Quarter 2008 Filed Jul 16, 2008 Signed by Patricia Knight, President

Official filing
Firm
KNIGHT CAPITOL CONSULTANTS
Client
GENZYME CORPORATION
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent Reform (S. 1145, H.R. 1908)

LobbyistCovered position, as disclosed
PATRICIA KNIGHT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Medicare/Medicaid MMM

Repeal of clinical laboratory reimbursement demonstration program (H.R. 3453, S. 2099, S. 3101, H.R. 6331) Potential inclusion of renal-related drugs in bundled payments for End-Stage Renal Disease reimbursement (S. 3101, H.R. 6331) Follow-on biologics legislation (H.R. 1038, H.R. 5629, S. 1695)

LobbyistCovered position, as disclosed
PATRICIA KNIGHT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2099 (110th), S. 1695 (110th), H.R. 6331 (110th), H.R. 3453 (110th), S. 3101 (110th), H.R. 1038 (110th), H.R. 5629 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.